SlideShare a Scribd company logo
Introducing a Novel Model for Studying
Macrophage Homing into Atherosclerotic
Plaque in APOE-Deficient Mice
• S. Litovsky, P. Wyde, M. Madjid, A. Akhtar, S.W.
Casscells, M. Naghavi
• Texas Heart Institute and University of Texas-
Houston, Houston, USA
European Atherosclerosis Society Meeting
Salzburg, July 7-10, 2002
Why Study Monocyte Recruitment?
• Monocytes/Macrophages are key players
not only in plaque initiation but also in
plaque progression and complications
through several mechanisms.
Monocyte Recruitment into
Atherosclerotic Plaques
Quantification Methods
Review of the studies done by:
• Gerrity et al
• Steinberg et al
• Willerson et al
• The potential role of SPIO
Initial EM (electron microscopy) observation by
Gerrity et all (Artery 1980;8:208-14), led to the
hypothesis of “macrophage assisted lipid clearance
mechanism”.
The swine model of hypercholesterolemia was
employed. Yorkshire pigs were fed high cholesterol
diets and sacrificed at the ages of 12, 15 and 30
weeks. Samples of aortic arch areas were examined
by electron microscopy.
EM studies indicated bi-directional movement of
foam cells through the endothelium overlying
the fatty streak lesion.
The above mentioned phenomenon may explain
the stability of fatty streaks for a period of time.
It also explains that macrophages may initially
serve as carriers of lipid material out of the plaque.
However, focal endothelial damage would result
from this process, which may contribute to later
lesion progression by introducing SMC
proliferating factors into the wall.
In a 2nd
study by Gerrity et al (Atherosclerosis 1988;
71:17-25) an additional method to trace macrophages
was used:
Monocytes were isolated from peripheral blood of pigs with
hypercholesterolemia.
Monocytes were labeled with FITC (fluorocin
Isothiocyanate 1-hydrochloride)
Labeled monocytes were reinjected back into the animal.
Labeled cells were found in the blood.
Animals were killed after 9 days, followed by histologic
examination.
Result
1)FITC-labeled monocytes were found adherent
to the thickened site of the intima but not to
normal areas.
2)Labelled cells were also found within the
atherosclerotic lesions.
In the study by S. Patel, James T. Willerson and
Edward Yeh, (Circulation 1998;97:75-81), wild-type
mice peritoneal macrophages were labeled with
fluorescent latex microspheres and IV injected into
ApoE deficient mice.
Animals were sacrificed after 48 hours, and tissues
obtained for histology.
A quantitative survey was done to detect the number
of labeled macrophages in the arterial wall.
Antibodies to ICAM-1, integrin and E-selectin were
injected 6-8 hours before macrophage injection.
Results
-Study was performed in 2 groups, (control and test) with
respect to the use of antibodies.
-After 48 hours macrophages were observed adhering to
all stages of plaques.
-The mean number of macrophages in the proximal 1mm
of aortic root was estimated to be 143+17.
-Antibodies against ICAM-1 and integrin significantly
reduced the number of macrophage homing.
Steinberg et al (ATVB 2000;20:1976-82) reported on a
new method of detecting monocytes in the plaque.
The basic idea was the introduction into a recipient
animal of leukocytes differing from those of the recipient
by virtue of one easily identified and quantified genetic
marker.
Monocytes were transfused from a male donor into
a female recipient and PCR was used to amplify
the Sry gene (testis-determining gene) on the Y
chromosome.
Method
The animal model was the LDL receptor deficient mice.
Males and females from the same highly inbred strain
were used as donors and recipients, so that no significant
immune response occurred.
Females who were to be recipients, were fed an atherogenic
diet for 3-6 months, beginning at 6 to 9 months of age.
All animals showed lesions in the aortic arch covering 13%
to 49% of the total surface area.
Methods
(cont.)
Monocytes collected from male mice were injected into 3
female mice that served as controls. A second group of
three female mice also received IP cytokine injection
(TNF-α, IL-1β).
Twenty four hours later the animals were euthanized and
aorta obtained for the study.
Results
Cytokine-treated mice showed 100% more recruitment
of monocytes in the aortic wall, compared to the control
group.
There was no cytokine effect in the animals with >40%
of the aortic arch covered by lesions.
The data in the control animals showed that monocyte
recruitment continued even when 30% to 50% of the
aortic surface was covered by lesions, but the rate of
recruitment was slower than it was in the earlier
stages of the disease.
• Although very informative, all these
techniques are invasive and
therefore cannot be used sequentially
in the same experimental animal.
OBJECTIVE
• Work from our group and other laboratories has
shown that the tracer Superparamagnetic Iron
Oxide (SPIO) administered intravenously 5 to 7
days before magnetic resonance imaging localizes
to aortic atherosclerotic plaques of apoE k/o mice
in addition to the reticuloendothelial system
(RES).
• In the present study we assessed by histopathology
the effect of several cytokines on monocytes
homing into aortas of apoE k/o mice.
METHODS
• Eleven apoE k/o retired breeders, 11-months old,
were divided in 2 groups. Six received TNF-α
0.2μg, IL-1β 0.2μg and IFNγ 100U/g
intraperitoneally, the latter for 5 days; the five
control received 0.5 mL saline containing 1%
BSA. Three hours later, all the animals were
injected with SPIO (Feridex) 1 mMol/kg of iron.
• Seven days later, the recipients were euthanized,
the heart and aorta perfused under physiologic
pressure and the entire aorta studied histologically.
ApoE K/O mice with SPIO but
without Cytokine
H&E Iron Stain
APOE K/O Mice with SPIO and
Cytokines
H&E Iron Stain
Iron Deposition on the Edges of
Atherosclerotic Plaques
H&E Iron Stain
Iron Deposition in Endothelial Cells
IMMUNOHISTOCHEMISTRY
MAC Stain CD3 Stain
Intramural Coronary Involvement
and Myocardial Injury
CONCLUSIONS
• Numerous iron particles are detected
subendothelially in the aorta specimens of
apoE k/o mice that received cytokines and
SPIO intravenously 7 days before sacrifice.
• Aortic iron particle levels are much lower in
mice not treated with cytokines.
IMPLICATIONS
• Since SPIO is a contrast agent used in
magnetic resonance imaging, this agent
offers great hope of studying monocyte
recruitment into the atherosclerotic plaque
non-invasively.

More Related Content

What's hot

How Does Inflammation in the Adipose Tissue Contribute to Diabetes
How Does Inflammation in the Adipose Tissue Contribute to DiabetesHow Does Inflammation in the Adipose Tissue Contribute to Diabetes
How Does Inflammation in the Adipose Tissue Contribute to Diabetes
Kiana Khosravian
 
Biopta company presentation
Biopta company presentationBiopta company presentation
Biopta company presentation
Biopta Inc.
 
Potentals of human amniotic fluid stem cells
Potentals of human amniotic fluid stem cellsPotentals of human amniotic fluid stem cells
Potentals of human amniotic fluid stem cells
Peyman Ghoraishizadeh
 
List Publication Complete 2016(Final)
List Publication Complete 2016(Final)List Publication Complete 2016(Final)
List Publication Complete 2016(Final)
Ahmed Hassan Sayed
 
Gene array study of vp
Gene array study of vpGene array study of vp
225 animal models of heart attack part 2
225 animal models of heart attack part 2225 animal models of heart attack part 2
225 animal models of heart attack part 2
Society for Heart Attack Prevention and Eradication
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch editorial - v2 n2- 2002
Vp watch   editorial - v2 n2- 2002Vp watch   editorial - v2 n2- 2002
Vp watch editorial - v2 n2- 2002
Society for Heart Attack Prevention and Eradication
 
Sigma Xi Research Showcase Slide Presentation
Sigma Xi Research Showcase Slide PresentationSigma Xi Research Showcase Slide Presentation
Sigma Xi Research Showcase Slide Presentation
Nick Smith
 
050 periadventitial fat
050 periadventitial fat050 periadventitial fat
Aha periadventitial fat
Aha periadventitial fatAha periadventitial fat
Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...
Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...
Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...
IJEAB
 
Citotoxic effects of oxytetracycline's residues contained in pet food
Citotoxic effects of oxytetracycline's residues contained in pet foodCitotoxic effects of oxytetracycline's residues contained in pet food
Citotoxic effects of oxytetracycline's residues contained in pet food
Sergio Canello
 
(Proteína G) Luis Velasquez Cumplido
(Proteína G) Luis Velasquez Cumplido (Proteína G) Luis Velasquez Cumplido
(Proteína G) Luis Velasquez Cumplido
Luis Alberto Velasquez Cumplido
 
(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido
(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido
(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido
Luis Alberto Velasquez Cumplido
 
Arrowhead Poster
Arrowhead PosterArrowhead Poster
Arrowhead Poster
Adam Ashton Kinion, MS
 
Intox por ivermectinas
Intox por ivermectinasIntox por ivermectinas
Intox por ivermectinas
Roberio Olinda
 

What's hot (17)

How Does Inflammation in the Adipose Tissue Contribute to Diabetes
How Does Inflammation in the Adipose Tissue Contribute to DiabetesHow Does Inflammation in the Adipose Tissue Contribute to Diabetes
How Does Inflammation in the Adipose Tissue Contribute to Diabetes
 
Biopta company presentation
Biopta company presentationBiopta company presentation
Biopta company presentation
 
Potentals of human amniotic fluid stem cells
Potentals of human amniotic fluid stem cellsPotentals of human amniotic fluid stem cells
Potentals of human amniotic fluid stem cells
 
List Publication Complete 2016(Final)
List Publication Complete 2016(Final)List Publication Complete 2016(Final)
List Publication Complete 2016(Final)
 
Gene array study of vp
Gene array study of vpGene array study of vp
Gene array study of vp
 
225 animal models of heart attack part 2
225 animal models of heart attack part 2225 animal models of heart attack part 2
225 animal models of heart attack part 2
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp watch editorial - v2 n2- 2002
Vp watch   editorial - v2 n2- 2002Vp watch   editorial - v2 n2- 2002
Vp watch editorial - v2 n2- 2002
 
Sigma Xi Research Showcase Slide Presentation
Sigma Xi Research Showcase Slide PresentationSigma Xi Research Showcase Slide Presentation
Sigma Xi Research Showcase Slide Presentation
 
050 periadventitial fat
050 periadventitial fat050 periadventitial fat
050 periadventitial fat
 
Aha periadventitial fat
Aha periadventitial fatAha periadventitial fat
Aha periadventitial fat
 
Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...
Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...
Haematological and Serum Biochemical Parameters of Mature Harco Cocks Treated...
 
Citotoxic effects of oxytetracycline's residues contained in pet food
Citotoxic effects of oxytetracycline's residues contained in pet foodCitotoxic effects of oxytetracycline's residues contained in pet food
Citotoxic effects of oxytetracycline's residues contained in pet food
 
(Proteína G) Luis Velasquez Cumplido
(Proteína G) Luis Velasquez Cumplido (Proteína G) Luis Velasquez Cumplido
(Proteína G) Luis Velasquez Cumplido
 
(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido
(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido
(Reproductive biology and endocrinology) Luis Alberto Velasquez Cumplido
 
Arrowhead Poster
Arrowhead PosterArrowhead Poster
Arrowhead Poster
 
Intox por ivermectinas
Intox por ivermectinasIntox por ivermectinas
Intox por ivermectinas
 

Viewers also liked

8
88
241 genetic influence on carotid atherosclerosis
241 genetic influence on carotid atherosclerosis241 genetic influence on carotid atherosclerosis
241 genetic influence on carotid atherosclerosis
SHAPE Society
 
134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging
SHAPE Society
 
034 everybody has atherosclerosis
034 everybody has atherosclerosis034 everybody has atherosclerosis
034 everybody has atherosclerosis
SHAPE Society
 
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
SHAPE Society
 
089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging
SHAPE Society
 
117 mr images of human carotid arteries
117 mr images of human carotid arteries117 mr images of human carotid arteries
117 mr images of human carotid arteries
SHAPE Society
 
236 complement inhibitor
236 complement inhibitor236 complement inhibitor
236 complement inhibitor
SHAPE Society
 
167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media
SHAPE Society
 
3rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 23rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 2
SHAPE Society
 
033 uptakes of spio by murine
033 uptakes of spio by murine033 uptakes of spio by murine
033 uptakes of spio by murine
SHAPE Society
 
251 computed tomographic coronary artery calcium
251 computed tomographic coronary artery calcium251 computed tomographic coronary artery calcium
251 computed tomographic coronary artery calcium
SHAPE Society
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
SHAPE Society
 
234 aha 2002 guideline, 1997 or 2002
234 aha 2002 guideline, 1997 or 2002234 aha 2002 guideline, 1997 or 2002
234 aha 2002 guideline, 1997 or 2002
SHAPE Society
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
SHAPE Society
 
094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter
SHAPE Society
 
Coronary artery disease among asymptomatic diabetic and non-diabetic patients...
Coronary artery disease among asymptomatic diabetic and non-diabetic patients...Coronary artery disease among asymptomatic diabetic and non-diabetic patients...
Coronary artery disease among asymptomatic diabetic and non-diabetic patients...
SHAPE Society
 
183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance
SHAPE Society
 
246 recombinant apolipoprotein ai milano
246 recombinant apolipoprotein ai milano246 recombinant apolipoprotein ai milano
246 recombinant apolipoprotein ai milano
SHAPE Society
 
125 ct based characterization
125 ct based characterization125 ct based characterization
125 ct based characterization
SHAPE Society
 

Viewers also liked (20)

8
88
8
 
241 genetic influence on carotid atherosclerosis
241 genetic influence on carotid atherosclerosis241 genetic influence on carotid atherosclerosis
241 genetic influence on carotid atherosclerosis
 
134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging
 
034 everybody has atherosclerosis
034 everybody has atherosclerosis034 everybody has atherosclerosis
034 everybody has atherosclerosis
 
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
 
089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging
 
117 mr images of human carotid arteries
117 mr images of human carotid arteries117 mr images of human carotid arteries
117 mr images of human carotid arteries
 
236 complement inhibitor
236 complement inhibitor236 complement inhibitor
236 complement inhibitor
 
167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media
 
3rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 23rd vulnerable plaque rumberg 3 16-02 2
3rd vulnerable plaque rumberg 3 16-02 2
 
033 uptakes of spio by murine
033 uptakes of spio by murine033 uptakes of spio by murine
033 uptakes of spio by murine
 
251 computed tomographic coronary artery calcium
251 computed tomographic coronary artery calcium251 computed tomographic coronary artery calcium
251 computed tomographic coronary artery calcium
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
234 aha 2002 guideline, 1997 or 2002
234 aha 2002 guideline, 1997 or 2002234 aha 2002 guideline, 1997 or 2002
234 aha 2002 guideline, 1997 or 2002
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter
 
Coronary artery disease among asymptomatic diabetic and non-diabetic patients...
Coronary artery disease among asymptomatic diabetic and non-diabetic patients...Coronary artery disease among asymptomatic diabetic and non-diabetic patients...
Coronary artery disease among asymptomatic diabetic and non-diabetic patients...
 
183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance
 
246 recombinant apolipoprotein ai milano
246 recombinant apolipoprotein ai milano246 recombinant apolipoprotein ai milano
246 recombinant apolipoprotein ai milano
 
125 ct based characterization
125 ct based characterization125 ct based characterization
125 ct based characterization
 

Similar to 042 introducing a novel model

Monocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaquesMonocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaques
Society for Heart Attack Prevention and Eradication
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
Society for Heart Attack Prevention and Eradication
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
SHAPE Society
 
International Journal of Hepatology & Gastroenterology
International Journal of Hepatology & GastroenterologyInternational Journal of Hepatology & Gastroenterology
International Journal of Hepatology & Gastroenterology
SciRes Literature LLC. | Open Access Journals
 
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
cordbloodsymposium
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
SHAPE Society
 
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
SHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
Society for Heart Attack Prevention and Eradication
 
Biomathematical Analysis of the Liver Fibrosis
Biomathematical Analysis of the Liver FibrosisBiomathematical Analysis of the Liver Fibrosis
Biomathematical Analysis of the Liver Fibrosis
submissionclinmedima
 
Transplantation
Transplantation Transplantation
Transplantation
Mohamed BADR
 
052 non invasive high resolution detection
052 non invasive high resolution detection052 non invasive high resolution detection
052 non invasive high resolution detection
Society for Heart Attack Prevention and Eradication
 
052 non invasive high resolution detection
052 non invasive high resolution detection052 non invasive high resolution detection
052 non invasive high resolution detection
SHAPE Society
 
Spio mri studies by dr naghavi
Spio mri studies by dr naghavi Spio mri studies by dr naghavi
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...
Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...
Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
 
Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...
Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...
Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...
SSR Institute of International Journal of Life Sciences
 
Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...
Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...
Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
 
Induced Pluripotent Stemcells: A P4 Perspective
Induced Pluripotent Stemcells: A P4 PerspectiveInduced Pluripotent Stemcells: A P4 Perspective
Induced Pluripotent Stemcells: A P4 Perspective
The Ohio State University Wexner Medical Center
 

Similar to 042 introducing a novel model (20)

Monocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaquesMonocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaques
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
 
International Journal of Hepatology & Gastroenterology
International Journal of Hepatology & GastroenterologyInternational Journal of Hepatology & Gastroenterology
International Journal of Hepatology & Gastroenterology
 
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
Deriving Mesenchymal Stem Cells from Human Amniotic Fluid – Potential for an ...
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits051 plaque inflam detection in atherosclerotic rabbits
051 plaque inflam detection in atherosclerotic rabbits
 
Biomathematical Analysis of the Liver Fibrosis
Biomathematical Analysis of the Liver FibrosisBiomathematical Analysis of the Liver Fibrosis
Biomathematical Analysis of the Liver Fibrosis
 
Transplantation
Transplantation Transplantation
Transplantation
 
052 non invasive high resolution detection
052 non invasive high resolution detection052 non invasive high resolution detection
052 non invasive high resolution detection
 
052 non invasive high resolution detection
052 non invasive high resolution detection052 non invasive high resolution detection
052 non invasive high resolution detection
 
Spio mri studies by dr naghavi
Spio mri studies by dr naghavi Spio mri studies by dr naghavi
Spio mri studies by dr naghavi
 
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...
Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...
Pretreatment with Paricalcitol Attenuates Oxidative Stress in Renal Ischemia ...
 
Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...
Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...
Serum Biochemical and Histopathological Changes in Rats Experimentally Infect...
 
Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...
Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...
Investigation of the Effects of Carvacrol on Experimental Ischemia/Reperfusio...
 
Induced Pluripotent Stemcells: A P4 Perspective
Induced Pluripotent Stemcells: A P4 PerspectiveInduced Pluripotent Stemcells: A P4 Perspective
Induced Pluripotent Stemcells: A P4 Perspective
 

More from SHAPE Society

Barth imt
Barth imtBarth imt
Barth imt
SHAPE Society
 
Braunwald
BraunwaldBraunwald
Braunwald
SHAPE Society
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
SHAPE Society
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
SHAPE Society
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
SHAPE Society
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
SHAPE Society
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
SHAPE Society
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
SHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
SHAPE Society
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
SHAPE Society
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
SHAPE Society
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
SHAPE Society
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
SHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
SHAPE Society
 
A20 gene
A20 geneA20 gene
A20 gene
SHAPE Society
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
SHAPE Society
 
103100
103100103100
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
SHAPE Society
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
SHAPE Society
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02
SHAPE Society
 

More from SHAPE Society (20)

Barth imt
Barth imtBarth imt
Barth imt
 
Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
103100
103100103100
103100
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02
 

Recently uploaded

Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 

Recently uploaded (20)

Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 

042 introducing a novel model

  • 1. Introducing a Novel Model for Studying Macrophage Homing into Atherosclerotic Plaque in APOE-Deficient Mice • S. Litovsky, P. Wyde, M. Madjid, A. Akhtar, S.W. Casscells, M. Naghavi • Texas Heart Institute and University of Texas- Houston, Houston, USA European Atherosclerosis Society Meeting Salzburg, July 7-10, 2002
  • 2. Why Study Monocyte Recruitment? • Monocytes/Macrophages are key players not only in plaque initiation but also in plaque progression and complications through several mechanisms.
  • 3. Monocyte Recruitment into Atherosclerotic Plaques Quantification Methods
  • 4. Review of the studies done by: • Gerrity et al • Steinberg et al • Willerson et al • The potential role of SPIO
  • 5. Initial EM (electron microscopy) observation by Gerrity et all (Artery 1980;8:208-14), led to the hypothesis of “macrophage assisted lipid clearance mechanism”. The swine model of hypercholesterolemia was employed. Yorkshire pigs were fed high cholesterol diets and sacrificed at the ages of 12, 15 and 30 weeks. Samples of aortic arch areas were examined by electron microscopy.
  • 6. EM studies indicated bi-directional movement of foam cells through the endothelium overlying the fatty streak lesion. The above mentioned phenomenon may explain the stability of fatty streaks for a period of time. It also explains that macrophages may initially serve as carriers of lipid material out of the plaque. However, focal endothelial damage would result from this process, which may contribute to later lesion progression by introducing SMC proliferating factors into the wall.
  • 7. In a 2nd study by Gerrity et al (Atherosclerosis 1988; 71:17-25) an additional method to trace macrophages was used: Monocytes were isolated from peripheral blood of pigs with hypercholesterolemia. Monocytes were labeled with FITC (fluorocin Isothiocyanate 1-hydrochloride) Labeled monocytes were reinjected back into the animal. Labeled cells were found in the blood. Animals were killed after 9 days, followed by histologic examination.
  • 8. Result 1)FITC-labeled monocytes were found adherent to the thickened site of the intima but not to normal areas. 2)Labelled cells were also found within the atherosclerotic lesions.
  • 9. In the study by S. Patel, James T. Willerson and Edward Yeh, (Circulation 1998;97:75-81), wild-type mice peritoneal macrophages were labeled with fluorescent latex microspheres and IV injected into ApoE deficient mice. Animals were sacrificed after 48 hours, and tissues obtained for histology. A quantitative survey was done to detect the number of labeled macrophages in the arterial wall. Antibodies to ICAM-1, integrin and E-selectin were injected 6-8 hours before macrophage injection.
  • 10. Results -Study was performed in 2 groups, (control and test) with respect to the use of antibodies. -After 48 hours macrophages were observed adhering to all stages of plaques. -The mean number of macrophages in the proximal 1mm of aortic root was estimated to be 143+17. -Antibodies against ICAM-1 and integrin significantly reduced the number of macrophage homing.
  • 11. Steinberg et al (ATVB 2000;20:1976-82) reported on a new method of detecting monocytes in the plaque. The basic idea was the introduction into a recipient animal of leukocytes differing from those of the recipient by virtue of one easily identified and quantified genetic marker. Monocytes were transfused from a male donor into a female recipient and PCR was used to amplify the Sry gene (testis-determining gene) on the Y chromosome.
  • 12. Method The animal model was the LDL receptor deficient mice. Males and females from the same highly inbred strain were used as donors and recipients, so that no significant immune response occurred. Females who were to be recipients, were fed an atherogenic diet for 3-6 months, beginning at 6 to 9 months of age. All animals showed lesions in the aortic arch covering 13% to 49% of the total surface area.
  • 13. Methods (cont.) Monocytes collected from male mice were injected into 3 female mice that served as controls. A second group of three female mice also received IP cytokine injection (TNF-α, IL-1β). Twenty four hours later the animals were euthanized and aorta obtained for the study.
  • 14. Results Cytokine-treated mice showed 100% more recruitment of monocytes in the aortic wall, compared to the control group. There was no cytokine effect in the animals with >40% of the aortic arch covered by lesions. The data in the control animals showed that monocyte recruitment continued even when 30% to 50% of the aortic surface was covered by lesions, but the rate of recruitment was slower than it was in the earlier stages of the disease.
  • 15. • Although very informative, all these techniques are invasive and therefore cannot be used sequentially in the same experimental animal.
  • 16. OBJECTIVE • Work from our group and other laboratories has shown that the tracer Superparamagnetic Iron Oxide (SPIO) administered intravenously 5 to 7 days before magnetic resonance imaging localizes to aortic atherosclerotic plaques of apoE k/o mice in addition to the reticuloendothelial system (RES). • In the present study we assessed by histopathology the effect of several cytokines on monocytes homing into aortas of apoE k/o mice.
  • 17. METHODS • Eleven apoE k/o retired breeders, 11-months old, were divided in 2 groups. Six received TNF-α 0.2μg, IL-1β 0.2μg and IFNγ 100U/g intraperitoneally, the latter for 5 days; the five control received 0.5 mL saline containing 1% BSA. Three hours later, all the animals were injected with SPIO (Feridex) 1 mMol/kg of iron. • Seven days later, the recipients were euthanized, the heart and aorta perfused under physiologic pressure and the entire aorta studied histologically.
  • 18. ApoE K/O mice with SPIO but without Cytokine H&E Iron Stain
  • 19. APOE K/O Mice with SPIO and Cytokines H&E Iron Stain
  • 20. Iron Deposition on the Edges of Atherosclerotic Plaques H&E Iron Stain
  • 21. Iron Deposition in Endothelial Cells
  • 24. CONCLUSIONS • Numerous iron particles are detected subendothelially in the aorta specimens of apoE k/o mice that received cytokines and SPIO intravenously 7 days before sacrifice. • Aortic iron particle levels are much lower in mice not treated with cytokines.
  • 25. IMPLICATIONS • Since SPIO is a contrast agent used in magnetic resonance imaging, this agent offers great hope of studying monocyte recruitment into the atherosclerotic plaque non-invasively.